Companies · Other Health Care

National Spine & Pain Centers Holdings, LLC

ROCKVILLE · Other Health Care

Diligence memoA one-page analyst read on National Spine & Pain Centers Holdings, LLC — recommendation, valuation, rhythm, risks.→
$32.0M
Total raised · real
1
Rounds
—
Latest step-up
Top 12%
Sector rank · raised
Series B
Latest stage · inferred · Fri Mar 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

National Spine & Pain Centers Holdings, LLC looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 1.89× the median modeled value of Series B Other Health Care companies in 2019–2021 (78 peers) — value vs value, same stage and era.
Dormant
  • Last raise 7.3 yr ago; this sector typically re-raises about every 14 months.
  • Only one round on record and long silent — often defunct, acquired, or gone quiet.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

National Spine & Pain Centers Holdings, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
7.5 yr record
Peak capital year was 2019 with $32.0M across 1 filings.
Market position
ahead of 89% of Other Health Care peers
Capital scale is ahead of 89% of Other Health Care peers; modeled value is above 95% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2019: $32.0M across 1 filings.
  • Largest single filing was $32.0M on 2019-03-29.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

National Spine & Pain Centers Holdings, LLC is one of 5377 Other Health Care companies tracked from ROCKVILLE. By capital raised it ranks in the upper tier (ahead of 89% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
30
Investors (latest)
2019-03-29
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeries B · 2019-03-29 Raised $32M (real) Modeled valuation $709M (est)$32M$709MSeries B2019

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series B$32.0M · 2019

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 25%.

Modeled valuation trajectory
$708.9M
Base estimate est.
$75.2M
Conservative case
$2.7B
Upside case
$177.8M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series B — a $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.36×/yr
Annual markup
1.64×/yr upside case
6.0 yr
Elapsed time used
7.3 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
—
Avg between rounds
—
Capital velocity
7.5 yr
On record since
2019
First round
1
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages)▲ 13× above median
This company$32.0M
Sector median$2.4M
Latest round — vs other Series B rounds in sector (real $, this stage)▲ 1.8× above median
This company$32.0M
Sector median$17.8M
Modeled value — vs sector median (estimate, all stages)▲ 32× above median
This company$708.9M
Sector median$22.1M

Raised more than 89% of sector peers (real $). Modeled value above 95% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #7 of 78.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0MCapital raised (log)KSMS Holdings, LLC · Series B Raised $40.0M · modeled $885.1M (est)Infab HoldCo, Inc. · Series B Raised $36.5M · modeled $807.5M (est)Aquity Holdings, Inc. · Series B Raised $36.0M · modeled $797.6M (est)MHH Management Holdco, LLC · Series B Raised $35.1M · modeled $777.6M (est)Earli Inc. · Series B Raised $40.0M · modeled $757.1M (est)Encore Dermatology, Inc. · Series B Raised $89.6M · modeled $729.9M (est)In Vitro Sciences, LLC · Series B Raised $31.5M · modeled $697.9M (est)Lotus Parent, Inc. · Series B Raised $31.2M · modeled $690.4M (est)Iron Oak Holdings LLC · Series B Raised $30.0M · modeled $664.6M (est)Squid Ink, Inc. · Series B Raised $30.2M · modeled $621.4M (est)Predict Innovation Investors, Llc · Series B Raised $27.9M · modeled $617.4M (est)National Spine & Pain Centers Holdings, LLC (this company) Raised $32.0M · modeled $708.9M (est)National Spine & Pain Centers Holdings, LLC
CompanyStageRaised · realValue · estvs peer med.
KSMS Holdings, LLCSeries B$40.0M$885.1M2.36×
Infab HoldCo, Inc.Series B$36.5M$807.5M2.16×
Aquity Holdings, Inc.Series B$36.0M$797.6M2.13×
MHH Management Holdco, LLCSeries B$35.1M$777.6M2.08×
Earli Inc.Series B$40.0M$757.1M2.02×
Encore Dermatology, Inc.Series B$89.6M$729.9M1.95×
National Spine & Pain Centers Holdings, LLC this companySeries B$32.0M$708.9M1.89×
In Vitro Sciences, LLCSeries B$31.5M$697.9M1.86×
Lotus Parent, Inc.Series B$31.2M$690.4M1.84×
Iron Oak Holdings LLCSeries B$30.0M$664.6M1.78×
Squid Ink, Inc.Series B$30.2M$621.4M1.66×
Predict Innovation Investors, LlcSeries B$27.9M$617.4M1.65×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series B$32.0M2019-03-29$177.8M$708.9M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series B$32.0M2019-03-29
    • First recorded raise — entered as Series B.
    • 30 investors on this round.
Intelligence
—
Modeled next raise
$51.2M
Modeled next size est.range $33.3M–$81.9M
—
Last step-up
—
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Sriram Venkataraman—5 other2019-03
BRIAN MARKISON—2 other2019-03
DAVID MCCABE—2 other2019-03
Mark Coleman—2 other2019-03
Thompson Dean—2 other2019-03
Derace Schaffer—1 other2019-03
Jerome Rhodes—1 other2019-03
AMY DILCHER——2019-03
DOUGLAS WISOR——2019-03
KATHERINE VAN DEN HEUVEL——2019-03
RYAN MORAN——2019-03
Registry & provenance

National Spine & Pain Centers Holdings, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1706025
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
VA Pro 7 SNF Operations Holdings LLCOther Health CareSeries B$32.0M$333.3Msame sector · same stage
Smile Source Holdings, L.P.Other Health CareSeries B$32.2M$309.0Msame sector · same stage
QDP TopCo LLCOther Health CareSeries B$31.8M$704.5Msame sector · same stage
Vyaire Holding CoOther Health CareSeries B$31.5M$698.5Msame sector · same stage
Medical Solutions L.L.C.Other Health CareSeries B$32.5M$720.0Msame sector · same stage
In Vitro Sciences, LLCOther Health CareSeries B$31.5M$697.9Msame sector · same stage
World Heart CorpOther Health CareSeries B$32.6M$560.5Msame sector · same stage
Avalign Technologies Holdings, Inc.Other Health CareSeries B$31.4M$694.5Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Spine Holdings LLCOther Health CareSeries B$851.6M92%
Center for Spine Surgery, LLCOther Health CarePre-Seed$8.4M90%
N H Spine & Ortho, Inc.Other Health CarePre-Seed$22.5M90%
Spine & Rehab Investors, LLCOther Health CareSeed$11.4M90%
American Pain Consortium Holdings, LLCOther Health CareSeries C$763.5M88%
Cardinal Spine, LLCOther Health CarePre-Seed$23.0M87%
Centinel Spine, LLCOther Health CareSeries D+$34.3M86%
U.S. NeuroSurgical Holdings, Inc.Other Health CareSeries A$16.3M86%
Frequently asked
How much funding has National Spine & Pain Centers Holdings, LLC raised?
National Spine & Pain Centers Holdings, LLC has raised approximately $32.0M in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is National Spine & Pain Centers Holdings, LLC's estimated valuation?
Provath's modeled valuation for National Spine & Pain Centers Holdings, LLC is approximately $708.9M (modeled range $75.2M–$2.7B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is National Spine & Pain Centers Holdings, LLC at?
National Spine & Pain Centers Holdings, LLC's latest modeled financing stage is Series B. Its most recent recorded round closed around Fri Mar 29.
What does National Spine & Pain Centers Holdings, LLC do and where is it based?
National Spine & Pain Centers Holdings, LLC operates in the Other Health Care sector, based in ROCKVILLE.
Explore related

See where National Spine & Pain Centers Holdings, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at National Spine & Pain Centers Holdings, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.